Veille scientifique COVID-19

Veille scientifique COVID-19
Bulletin du 10/06/2021


Pour consulter l'ensemble des articles par catégorie, en ordre décroissant de parution, cliquer sur un des liens suivants :



À ne pas manquer

BNT162b2 vaccine effectiveness in preventing asymptomatic infection with SARS-CoV-2 virus: a nationwide historical cohort study

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19

Does reactogenicity after a second injection of the BNT162b2 vaccine predict spike IgG antibody levels in healthy Japanese subjects?

BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants

First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland

Delayed Large Local Reactions to mRNA Covid-19 Vaccines in Blacks, Indigenous Persons, and People of Color

Declined Antibody Responses to COVID-19 mRNA Vaccine within First Three Months

The importance of time post-vaccination in determining the decrease in vaccine efficacy against SARS-CoV-2 variants of concern

Highly-specific memory B cells generation after the 2nd dose of BNT162b2 vaccine compensate for the decline of serum antibodies and absence of mucosal IgA

BNT162b2 mRNA vaccinations in Israel: understanding the impact and improving the vaccination policies by redefining the immunized population

Genome-wide analysis in 756,646 individuals provides first genetic evidence that ACE2 expression influences COVID-19 risk and yi...

Possible future waves of SARS-CoV-2 infection generated by variants of concern with a range of characteristics

Genomic Surveillance for SARS-CoV-2 Variants Circulating in the United States, December 2020-May 2021

Modelling the effect of an improved trace and isolate system in the wake of a highly transmissible Covid-19 variant with potential vaccine escape

The potential of SARS-CoV-2 antigen-detection tests in the screening of asymptomatic persons

The protective effect of SARS-CoV-2 antibodies in Scottish healthcare workers

Portal vein thrombosis associated with ChAdOx1 nCov-19 vaccination

Anti-SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis

Increased household secondary attacks rates with Variant of Concern SARS-CoV-2 index cases

A model and predictions for COVID-19 considering population behavior and vaccination

Determining quarantine length and testing frequency for international border opening

SARS-CoV-2 reinfection with a virus harboring mutation in the Spike and the Nucleocapsid proteins in Panama

Association between risk of VTE and mortality in patients with COVID-19

Preventing COVID-19 Transmission in Education Settings

Persistence of SARS-CoV-2 RNA in lung tissue after mild COVID-19

Inflammatory biomarkers in COVID-19-associated multisystem inflammatory syndrome in children, Kawasaki disease, and macrophage activation syndrome: a cohort study

SARS-CoV-2 emerging variants in Africa: view from Gabon

SARS-CoV-2 infection in pregnancy in Denmark - characteristics and outcomes after confirmed infection in pregnancy: a nationwide, prospective, population-based cohort study

SARS-CoV-2 seroprevalence in students and teachers: a longitudinal study from May to October 2020 in German secondary schools

Clinical and molecular characteristics of COVID-19 patients with persistent SARS-CoV-2 infection

© TOUS DROITS RÉSERVÉS 2018 - Association des gens d'affaires et professionels